Background: Clopidogrel is an antiplatelet drug increasingly used in the secondary prevention of atherosclerotic vascular events. Compared with aspirin, clopidogrel has marginal additional efficacy and similar safety, but carries a substantial price premium. It remains unclear whether its use is cost-effective
Background: The optimal aspirin dose for the prevention of cardiovascular events remains controversi...
Antiplatelet therapy is the mainstay of treatment and secondary prevention of cardiovascular disease...
Whether clopidogrel should be added to aspirin for stroke prevention remained controversial for the ...
noThe National Audit Office (NAO) has produced prescribing indicators that Primary Care Trusts (PCTs...
Background The National Audit Office (NAO) has produced prescribing indicators that Primary Care Tru...
Aim: To develop guidelines for clopidogrel prescribing and survey its use to ascertain the need for ...
Combination antiplatelet therapy, typically with clopidogrel and aspirin, is commonly used for the p...
The antiplatelet clopidogrel and the proton pump inhibitor esomeprazole demonstrate a pharmacokineti...
Background: Clopidogrel is used for the secondary prevention of cerebrovascular and cardiovascular e...
Aspirin and clopidogrel are the commonest dual antiplatelet agents being used in the secondary preve...
The use of multiple medications (ie,polypharmacy) has no standard defi-nition in the medical literat...
Antiplatelet agents are mainly used in the prevention and management of atherothrombotic complicatio...
Background If percutaneous coronary intervention (PCI) is required in patients taking oral anticoagu...
Background If percutaneous coronary intervention (PCI) is required in patients taking oral anticoagu...
Combined antiplatelet treatment with aspirin and clopidogrel is pivotal to minimize periprocedural a...
Background: The optimal aspirin dose for the prevention of cardiovascular events remains controversi...
Antiplatelet therapy is the mainstay of treatment and secondary prevention of cardiovascular disease...
Whether clopidogrel should be added to aspirin for stroke prevention remained controversial for the ...
noThe National Audit Office (NAO) has produced prescribing indicators that Primary Care Trusts (PCTs...
Background The National Audit Office (NAO) has produced prescribing indicators that Primary Care Tru...
Aim: To develop guidelines for clopidogrel prescribing and survey its use to ascertain the need for ...
Combination antiplatelet therapy, typically with clopidogrel and aspirin, is commonly used for the p...
The antiplatelet clopidogrel and the proton pump inhibitor esomeprazole demonstrate a pharmacokineti...
Background: Clopidogrel is used for the secondary prevention of cerebrovascular and cardiovascular e...
Aspirin and clopidogrel are the commonest dual antiplatelet agents being used in the secondary preve...
The use of multiple medications (ie,polypharmacy) has no standard defi-nition in the medical literat...
Antiplatelet agents are mainly used in the prevention and management of atherothrombotic complicatio...
Background If percutaneous coronary intervention (PCI) is required in patients taking oral anticoagu...
Background If percutaneous coronary intervention (PCI) is required in patients taking oral anticoagu...
Combined antiplatelet treatment with aspirin and clopidogrel is pivotal to minimize periprocedural a...
Background: The optimal aspirin dose for the prevention of cardiovascular events remains controversi...
Antiplatelet therapy is the mainstay of treatment and secondary prevention of cardiovascular disease...
Whether clopidogrel should be added to aspirin for stroke prevention remained controversial for the ...